Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Protein Found to Play Key Role in Long Life

By BiotechDaily International staff writers
Posted on 02 Oct 2013
Image: The structure of the sirtuin protein Sirt1 (Photo courtesy of Shin-ichiro Imai/Washington University in St. Louis).
Image: The structure of the sirtuin protein Sirt1 (Photo courtesy of Shin-ichiro Imai/Washington University in St. Louis).
The process behind the functioning of a specific protein already believed to play a role in longevity has recently been established to do just that, lengthen lifespan.

Developmental biologist Dr. Shin-ichiro Imai, from Washington University in St. Louis (MO, USA), discovered that instead of delaying the aging process, the protein works in the brain to delay the onset of aging, thus extending youth and adding those energetic years onto one’s life span.

The researchers engineered lab mice that expressed higher than normal levels of Sirt1 in their brain and saw a substantial extension in the animals’ life spans. The scientists specifically found that Sirt1 plays a vital role in protecting against age-related declines in skeletal muscle, physical activity, body temperature, oxygen consumption, and quality of sleep. The start of the disease process in mice trigger to contract cancer was also delayed.

This new finding could help researchers better determine how to extend the life span of other mammals, including humans. The result is published September 3, 2013, in the journal Cell Metabolism.

Related Links:
Washington University in St. Louis


comments powered by Disqus

Channels

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.